Nintedanib drug page Clinical trials

Trials with Nintedanib

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

4Trials
0Recruiting
11Countries
832Planned patients

Showing 1–4 of 4

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]
Finished Phase 2 1 patients NCT02780700

The objective of this Phase II study is to assess the efficacy and safety of nintedanib alone or in combination with capecitabine for patients with refractory metastatic colorectal cancer (mCRC) after failure of at least 2 lines of standar…

United States Jul 2016 – Sept 2016 Interventional
Combined with: Capecitabine
Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors
Finished Phase 1 21 patients NCT02835833

Angiogenesis, the development of new blood vessels, plays an important role in the disease development and tumor growth in many solid organ malignancies. Bevacizumab was the first anti-angiogenic drug to be approved in solid tumors and has…

United States Jun 2016 – Jun 2018 Interventional
Combined with: Bevacizumab
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
Finished Phase 1 42 patients NCT02393755

This phase I/II trial studies the side effects and best dose of nintedanib when given together with capecitabine and to see how well they work in treating patients with colorectal cancer that has not responded to previous treatment (refrac…

United States May 2015 – May 2021 Interventional
Combined with: Capecitabine
Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
Finished Phase 3 768 patients NCT02149108

The objective of this Phase III study is to evaluate the efficacy of nintedanib in patients with metastatic colorectal cancer (mCRC) after failure of previous treatment with standard chemotherapy and biological agents.

United States, Argentina, Australia, Austria and 7 more Sept 2014 – Aug 2016 Interventional
Combined with: Bsc